Beyond amyloid and tau: rethinking Alzheimer’s disease through less explored avenues
Open Biology · 2024
DOI: 10.1098/rsob.240035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Open Biology, 2024. Verfasst von M Gyimesi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell and Neurogenesis Group, Genomics Research Centre, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland Un…. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Centre for Genomics and Personalised Health, QUT, Australian Government, Research Training Program (RTP).
Themen: Demenz
Abstract (Originalsprache)
Neurodegenerative diseases, particularly Alzheimer’s disease (AD), pose a significant challenge in ageing populations. Our current understanding indicates that the onset of toxic amyloid and tau protein pathologies initiates disease progression. However, existing treatments targeting these hallmark symptoms offer symptomatic relief without halting disease advancement. This review offers an alternative perspective on AD, centring on impaired adult hippocampal neurogenesis (AHN) as a potential early aetiological factor. By delving into the intricate molecular events during the initial stages of AD (Braak Stages I–III), a novel hypothesis is presented, interweaving the roles of Notch signalling and heparan sulfate proteoglycans (HSPGs) in compromised AHN. While acknowledging the significance of the amyloid and tau hypotheses, it calls for further exploration beyond these paradigms, suggesting the potential of altered HS sulfation patterns in AD initiation. Future directions propose more detailed investigations into early HS aggregation, aberrant sulfation patterns and examination of their temporal relationship with tau hyperphosphorylation. In challenging the conventional ‘triggers’ of AD and urging their reconsideration as symptoms, this review advocates an alternative approach to understanding this disease, offering new avenues of investigation into the intricacies of AD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cell and Neurogenesis Group, Genomics Research Centre, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), 60 Musk Ave , Kelvin Grove, Queensland 4…
- Max Planck Queensland Centre for the Materials Sciences of Extracellular Matrices , Brisbane, QLD 4059, Australia.
- Centre for Biomedical Technologies, Queensland University of Technology (QUT), 60 Musk Ave , Kelvin Grove, Queensland 4059, Australia.
- ARC Training Centre for Cell and Tissue Engineering Technologies , Brisbane, QLD 4059, Australia.
ORCID-Profile: L M Haupt
Förderung
- the Centre for Genomics and Personalised Health, QUT
- Australian Government
- Research Training Program (RTP)
- National Health and Medical Research Council-Australian Research
Zitieren
APA
Gyimesi, M., Okolicsanyi, R. K., & Haupt, L. M. (2024). Beyond amyloid and tau: rethinking Alzheimer’s disease through less explored avenues. Open Biology. https://doi.org/10.1098/rsob.240035
Vancouver
Gyimesi M, Okolicsanyi RK, Haupt LM. Beyond amyloid and tau: rethinking Alzheimer’s disease through less explored avenues. Open Biology. 2024. doi:10.1098/rsob.240035
BibTeX
@article{Gyimesi2024,
author = {Gyimesi, M and Okolicsanyi, R K and Haupt, L M},
title = {Beyond amyloid and tau: rethinking Alzheimer’s disease through less explored avenues},
journal = {Open Biology},
year = {2024},
doi = {10.1098/rsob.240035}
}
EUVIMED